0 Ratings
ID

11712

Description

The purpose of this study is to see if early INTEGRILIN® (eptifibatide) therapy in patients with non-ST-segment elevation acute coronary syndrome (ACS) reduces the occurence of death, heart attack and urgent cardiac intervention (surgery) compared to placebo (with delayed provisional use of eptifibatide). https://clinicaltrials.gov/ct2/show/NCT00089895

Link

https://clinicaltrials.gov/ct2/show/NCT00089895

Keywords

Versions (1)
  1. 7/28/15 7/28/15 -
Uploaded on

July 28, 2015

DOI

To request one please log in.

License

Creative Commons BY 4.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

  • Newest
  • Oldest
  • Popular
  • Newest
    • Newest
    • Oldest
    • Popular

    No comments

    In order to download data models you must be logged in. Please log in or register for free.

    Eligibility EARLY ACS Acute Coronary Syndrome NCT00089895

    English

    Eligibility criteria

    1 forms  
    1. StudyEvent: ODM
      1. Eligibility criteria
    Inclusion Criteria
    Description

    Inclusion Criteria

    Willing and able to give informed consent and comply with study procedures and follow-up through 1 year.
    Description

    Willing and able to give informed consent and comply with study procedures and follow-up through 1 year.

    Data type

    boolean

    Alias
    UMLS CUI-1
    C0021430
    symptoms of cardiac ischemia
    Description

    symptoms of cardiac ischemia

    Data type

    boolean

    Alias
    UMLS CUI-1
    C0151744
    60 years of age or more
    Description

    60 years of age or more

    Data type

    boolean

    Alias
    UMLS CUI-1
    C0001779
    Electrocardiogram changes
    Description

    Electrocardiogram changes

    Data type

    boolean

    Alias
    UMLS CUI-1
    C0855329
    Elevated troponin levels
    Description

    Elevated troponin

    Data type

    boolean

    Alias
    UMLS CUI-1
    C0523952
    Elevated CK-MB levels
    Description

    Elevated CK-MB levels

    Data type

    boolean

    Alias
    UMLS CUI-1
    C0523584
    Prior history of cardiovascular disease
    Description

    Prior history of cardiovascular disease

    Data type

    boolean

    Alias
    UMLS CUI-1
    C0455539
    Exclusion criteria
    Description

    Exclusion criteria

    pregnancy (known or suspected)
    Description

    pregnancy (known or suspected)

    Data type

    boolean

    Alias
    UMLS CUI-1
    C0549206
    renal dialysis within 30 days prior to randomizing in study
    Description

    renal dialysis within 30 days prior to randomizing in study

    Data type

    boolean

    Alias
    UMLS CUI-1
    C0019004
    Stroke
    Description

    Stroke

    Data type

    boolean

    Alias
    UMLS CUI-1
    C0038454
    central nervous system damage
    Description

    central nervous system damage

    Data type

    boolean

    Alias
    UMLS CUI-1
    C0007682
    bleeding disorders
    Description

    bleeding disorders

    Data type

    boolean

    Alias
    UMLS CUI-1
    C3251812
    major surgery
    Description

    major surgery

    Data type

    boolean

    Alias
    UMLS CUI-1
    C0679637
    major trauma
    Description

    major trauma

    Data type

    boolean

    Alias
    UMLS CUI-1
    C0332677
    treatment with heparin
    Description

    treatment with heparin

    Data type

    boolean

    Alias
    UMLS CUI-1
    C2825026
    Treatment with eptifibatide
    Description

    Treatment with eptifibatide

    Data type

    boolean

    Alias
    UMLS CUI-1
    C0253563
    Back to the top of the page

    Similar models

    Eligibility criteria

    1 forms
    1. StudyEvent: ODM
      1. Eligibility criteria
    Name
    Type
    Description | Question | Decode (Coded Value)
    Data type
    Alias
    Item Group
    Inclusion Criteria
    Informed consent
    Item
    Willing and able to give informed consent and comply with study procedures and follow-up through 1 year.
    boolean
    C0021430 (UMLS CUI-1)
    Myocardial Ischemia
    Item
    symptoms of cardiac ischemia
    boolean
    C0151744 (UMLS CUI-1)
    Age
    Item
    60 years of age or more
    boolean
    C0001779 (UMLS CUI-1)
    Electrocardiogram change
    Item
    Electrocardiogram changes
    boolean
    C0855329 (UMLS CUI-1)
    Troponin
    Item
    Elevated troponin levels
    boolean
    C0523952 (UMLS CUI-1)
    CK-MB
    Item
    Elevated CK-MB levels
    boolean
    C0523584 (UMLS CUI-1)
    History of cardiovascular disease
    Item
    Prior history of cardiovascular disease
    boolean
    C0455539 (UMLS CUI-1)
    Item Group
    Exclusion criteria
    Pregnancy
    Item
    pregnancy (known or suspected)
    boolean
    C0549206 (UMLS CUI-1)
    Hemodialysis
    Item
    renal dialysis within 30 days prior to randomizing in study
    boolean
    C0019004 (UMLS CUI-1)
    Stroke
    Item
    Stroke
    boolean
    C0038454 (UMLS CUI-1)
    CNS disorder
    Item
    central nervous system damage
    boolean
    C0007682 (UMLS CUI-1)
    Bleeding risk
    Item
    bleeding disorders
    boolean
    C3251812 (UMLS CUI-1)
    major surgery
    Item
    major surgery
    boolean
    C0679637 (UMLS CUI-1)
    major injury
    Item
    major trauma
    boolean
    C0332677 (UMLS CUI-1)
    Heparin
    Item
    treatment with heparin
    boolean
    C2825026 (UMLS CUI-1)
    Eptifibatide
    Item
    Treatment with eptifibatide
    boolean
    C0253563 (UMLS CUI-1)
    Back to the top of the page 

    Help

    Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

    Watch Tutorial